Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F23R9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,922
Award facts
- Contract value 100% obligated
- $44,922.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,922.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The contract, with an ultimate completion date of December 1, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This delivery order falls within the company's broader $999,999,999 pharmaceutical supply agreement (SPE2DX) that extends through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications and medical supplies to military healthcare programs worldwide. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen has demonstrated significant capability in fulfilling military and veteran healthcare supply requirements through multiple therapeutic domains. Zepbound, a GLP-1 receptor agonist used for weight management, reflects the company's role in supplying specialized pharmaceutical products to the Defense Health Agency and other government healthcare systems. The non-set-aside designation and firm fixed pricing structure are consistent with AmerisourceBergen's competitive standing as a federal pharmaceutical vendor and its position as a critical supplier within the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F23R9?
SPE2DR26F23R9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26F23R9 worth?
The government has obligated $44,922 on SPE2DR26F23R9.
Is contract SPE2DR26F23R9 an order under another contract?
Yes. SPE2DR26F23R9 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F23R9 competed?
The extent of competition for SPE2DR26F23R9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award